[1] John G, Laura L, Jesse M, et al.Rosai and Ackerman's Surgical Pathology[M]. 10 th. Beijing: Peking University Medical Press,2014.
[2] Buchner A, Leider AS, Merrell PW, et al.Melanocytic nevi of the oral mucosa: a clinicopathologic study of 130 cases from northern California[J]. J Oral Pathol Med,1990,19(5):197-201.
[3] Dohse L, Ferringer T.Nodal blue nevus: a pitfall in lymph node biopsies[J]. J Cutan Pathol,2010,37(1):102-104.
[4] Jiji V.Blue nevus of the endocervix. Review of the literature[J]. Arch Pathol,1971,92(3):203-205.
[5] Mancini L, Gubinelli M, Fortunato C, et al.Blue nevus of the lymph node capsule. Report of a case[J]. Pathologica,1992,84(1092):547-550.
[6] Masci P, Ciardi A, Di Tondo U.Blue nevus of the lymph node capsule[J]. J Dermatol Surg Oncol,1984,10(8):596-598.
[7] Tannenbaum M.Differential diagnosis in uropathology. Ⅲ Melanotic lesions of prostate: blue nevus and prostatic epithelial melanosis[J]. Urology,1974,4(5):617-621.
[8] Rodriguez HA, Ackerman LV.Cellular blue nevus. Clinicopathologic study of forty-five cases[J]. Cancer,1968,21(3):393-405.
[9] Tran TA, Carlson JA, Basaca PC, et al.Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases[J]. J Cutan Pathol,1998,25(5):252-258.
[10] Zembowicz A, Phadke PA.Blue nevi and variants: an update[J]. Arch Pathol Lab Med,2011,135(3):327-336.
[11] Krengel S, Scope A, Dusza SW, et al.New recommendations for the categorization of cutaneous features of congenital melanocytic nevi[J]. J Am Acad Dermatol,2013, 68(3):441-451.
[12] Alikhan A, Ibrahimi OA, Eisen DB.Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis[J]. J Am Acad Dermatol,2012,67(4):495.
[13] Tannous, ZS, et al.Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clini-cal management[J]. J Am Acad Dermatol,2005,52(2):197-203.
[14] Tannous ZS, Mihm MC Jr, Sober AJ, et al.Bekerecioglu,Comparison of classification systems for congenital melanocytic nevi[J]. Dermatol Surg,2010,36(10):1554-1562.
[15] Watt AJ, Kotsis SV, Chung KC.Risk of melanoma arising in large congenital melanocytic nevi: a systematic review[J]. Plast Reconstr Surg,2004,113(7):1968-1974.
[16] Vourc'h-Jourdain M, Martin L, Barbarot S, et al. Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review[J]. J Am Acad Dermatol,2013,68(3):493-498.
[17] Zaal LH, Mooi WJ, Klip H, et al.Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands[J]. Plast Reconstr Surg,2005,116(7):1902-1909.
[18] Sakamoto M, Morimoto N, Jinno C, et al.Melanin pigments in the melanocytic nevus regress spontaneously after inactivation by high hydrostatic pressure[J]. PLoS One,2017,12(11):e0186958.
[19] Gammon B, Gerami P.Fluorescence in situ hybridization for ambiguous melanocytic tumors[J]. Histol Histopathol,2012,27(12):1539-1542.
[20] Requena C, Rubio L, Traves V, et al.Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma[J]. Histopathology,2012,61(5):899-909.
[21] de la Fouchardière A1, Vergier B, et al. Vergier,Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)[J]. Ann Pathol,2011,31(5 Suppl):S115-S116.
[22] Abraham RM, Ming ME, Elder DE, et al.An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis[J]. J Cutan Pathol,2012,39(1):21-24.
[23] Baldwin L, Dunn J.Global controversies and advances in skin cancer[J]. Asian Pac J Cancer Prev,2013,14(4):2155-2157.
[24] Bresalier RS, Kopetz S, Brenner DE.Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?[J]. Dig Dis Sci,2015,60(3):664-671.
[25] Göppner D, Ulrich J, Pokrywka A, et al.Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm[J]. Dermatology,2011,222(1):59-66.
[26] Rigel DS, Carucci JA.Malignant melanoma: prevention, early detection, and treatment in the 21st century[J]. CA Cancer J Clin,2000,50(4):215-236.
[27] Rigel DS, Friedman RJ, Kopf AW, et al.ABCDE--an evolving concept in the early detection of melanoma[J]. Arch Dermatol,2005,141(8):1032-1034.
[28] 董小龙, 马勇光, 杨欣. 皮肤恶性黑色素瘤诊断及外科治疗策略[J]. 中国美容医学,2016,25(6):108-112.
[29] Satheesha TY, Satyanarayana D, Prasad MNG, et al.Melanoma Is Skin Deep: A 3D Reconstruction Technique for Computerized Dermoscopic Skin Lesion Classification[J]. IEEE J Transl Eng Health Med, 2017,5:4300117.
[30] Lang UE, Yeh I, McCalmont TH. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing[J]. Clin Lab Med,2017,37(3):473-484.
[31] Mesbah Ardakani N, Thomas C, Robinson C, et al.Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation[J]. Pathology,2017,49(3):285-291.
[32] Wang L, Rao M, Fang Y, et al.A genome-wide high-reso-lution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation[J]. J Mol Diagn,2013,15(5):581-591.
[33] McCalmont TH, Vemula S, Sands P, et al. Molecular-microscopical correlation in dermatopathology[J]. J Cutan Pathol,2011,38(4):324-326, 323.
[34] North JP, Garrido MC, Kolaitis NA, et al.Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases[J]. Am J Surg Pathol,2014,38(6):824-831.
[35] Yeh I, von Deimling A, Bastian BC. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia[J]. J Natl Cancer Inst,2013,105(12):917-919.
[36] van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi[J]. Nature,2009,457(7229):599-602.
[37] 郎中亮, 王明刚. 中国人群恶性黑色素瘤的临床特征研究进展[J]. 安徽医学,2018,39(1):120-122.
